Mera Pharmaceuticals, Inc.
MRPI
$0.00
$0.000.00%
OTC PK
| 10/31/2011 | 07/31/2011 | ||||
|---|---|---|---|---|---|
| Revenue | -26.38% | -0.57% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -26.38% | -0.57% | |||
| Cost of Revenue | 633.33% | -97.06% | |||
| Gross Profit | -28.67% | 12.19% | |||
| SG&A Expenses | 84.51% | -0.78% | |||
| Depreciation & Amortization | 0.00% | 61.54% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 56.69% | -14.62% | |||
| Operating Income | -415.42% | 46.97% | |||
| Income Before Tax | -447.15% | 50.39% | |||
| Income Tax Expenses | 2.86% | 10.26% | |||
| Earnings from Continuing Operations | -546.84% | 54.99% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -546.84% | 54.99% | |||
| EBIT | -415.42% | 46.97% | |||
| EBITDA | -466.48% | 51.23% | |||
| EPS Basic | -- | 100.00% | |||
| Normalized Basic EPS | -- | -- | |||
| EPS Diluted | -- | 100.00% | |||
| Normalized Diluted EPS | -- | -- | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||